Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Experimental Hematology ; (6): 563-566, 2007.
Artigo em Chinês | WPRIM | ID: wpr-276872

RESUMO

The study was aimed to generate monoclonal antibodies (mAbs) against homo sapiens UDP-glucose pyrophosphorylase 2 (UGP2). Normal human liver tissues homogenized, and cytosolic proteins isolated by centrifugation were used to immunize BALB/c mice to generate mAbs by hybridoma technique. The mAbs were identified by ELISA, Western blot, and immunohistochemistry assay. The antibody specificity was confirmed by Uni-ZAP expression library screening. The results indicated that one hybridoma BAD062 secreting specific mAb against UGP2 was established. The Ig subclass of this mAb was IgG(2b) (kappa), and it could be used in ELISA, Western blot, immunohistochemistry assay. The antigen recognized by BAD062 mAb was localized in the hepatocyte cytoplasm, with molecular weight of 56 kD in the cytosolic proteins of human liver tissue. The BAD062 mAb was further confirmed by immunoscreening of Uni-ZAP XR liver cDNA expression library. It is concluded that a hybridoma cell line stably secretes specific mAb against UGP2. This mAb reacted with UGP2 in ELISA, Western blot, immunohistochemistry assay, and would be very useful for the UGP2 studies.


Assuntos
Animais , Humanos , Camundongos , Anticorpos Monoclonais , Especificidade de Anticorpos , Sequência de Bases , Hibridomas , Secreções Corporais , Fígado , Metabolismo , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , UTP-Glucose-1-Fosfato Uridililtransferase , Alergia e Imunologia
2.
Journal of Experimental Hematology ; (6): 823-826, 2007.
Artigo em Chinês | WPRIM | ID: wpr-276814

RESUMO

This study was purposed to prepare and identify monoclonal antibodies (McAbs) against Homo sapiens hemoglobin alpha 2 (HBA2). Normal human fetal liver tissues were homogenized, and human liver nuclear proteins were isolated by centrifugation. The total human fetal liver nuclear proteins were used to immunize BALB/c mice for preparing McAbs by hybridoma technique. The McAbs specificity was identified by ELISA, Western blot, and immunohistochemistry. The antigen was identified by Uni-ZAP expression library screening. The results showed that one hybridoma cell line, AEE091, secreting specific McAb against HBA2 was established. The Ig subclass of this McAb was IgG1 (kappa). Data from immunohistochemistry assay showed that AEE091 could recognize human liver nuclear protein. Using AEE091 McAb, isolation of the protein antigen by IP revealed that AEE091 McAb could recognize 15 kD protein. Screening the Uni-ZAP XR pre-made liver cDNA library with AEE091 hybridoma cell supernatants demonstrated that AEE091 McAb specially reacted with HBA2. It is concluded that a hybridoma cell line stably secreting specific McAb against HBA2 is established. The specific McAb against HBA2 would be very useful for studying HBA2 function and screening thalassemia.


Assuntos
Animais , Humanos , Camundongos , Anticorpos Monoclonais , Alergia e Imunologia , Especificidade de Anticorpos , Sequência de Bases , Hemoglobina A2 , Alergia e Imunologia , Hibridomas , Secreções Corporais , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Talassemia alfa , Alergia e Imunologia
3.
Journal of Southern Medical University ; (12): 1044-1046, 2006.
Artigo em Chinês | WPRIM | ID: wpr-334996

RESUMO

<p><b>OBJECTIVE</b>To evaluate of therapeutic efficacy of deoxyribouncleotidum on pulmonary tuberculosis.</p><p><b>METHODS</b>Eighty patients with pulmonary tuberculosis sustaining hepatic lesion after treatment with antituberculosis drugs were randomized into therapeutic group and control group. Patients in the control group received regular treatment and those in the therapeutic group had additional deoxyribouncleotidum injection.</p><p><b>RESULTS</b>ALT, AST, ALP and TBIL levels were significantly higher in the therapeutic group than in the control group 4 weeks after treatment. IgG, IgA, IgM levels, and CD3(+) and CD8(+) lymphocytes were significantly increased in the therapeutic group after treatment (P<0.05).</p><p><b>CONCLUSION</b>deoxyribouncleotidum can improve hepatic function and immunity in patients with pulmonary tuberculosis.</p>


Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adjuvantes Imunológicos , Usos Terapêuticos , Alanina Transaminase , Metabolismo , Antituberculosos , Usos Terapêuticos , Aspartato Aminotransferases , Metabolismo , Complexo CD3 , Alergia e Imunologia , Linfócitos T CD8-Positivos , Biologia Celular , Alergia e Imunologia , Doença Hepática Induzida por Substâncias e Drogas , Desoxirribonucleotídeos , Usos Terapêuticos , Imunoglobulina A , Sangue , Imunoglobulina G , Sangue , Imunoglobulina M , Sangue , Injeções , Hepatopatias , Sangue , Tratamento Farmacológico , Resultado do Tratamento , Tuberculose Pulmonar , Sangue , Tratamento Farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA